Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
69.1M
Number of holders
170
Total 13F shares, excl. options
50.1M
Shares change
+625K
Total reported value, excl. options
$377M
Value change
+$2.35M
Put/Call ratio
0
Number of buys
87
Number of sells
-79
Price
$7.53

Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q1 2024

196 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50.1M shares of 69.1M outstanding shares and own 72.45% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.36M shares), VANGUARD GROUP INC (4.48M shares), WELLINGTON MANAGEMENT GROUP LLP (2.63M shares), Bank of New York Mellon Corp (2.49M shares), Daventry Group, LP (2.16M shares), Impax Asset Management Group plc (2.15M shares), PRIMECAP MANAGEMENT CO/CA/ (2.07M shares), Point72 Asset Management, L.P. (2.03M shares), DIMENSIONAL FUND ADVISORS LP (1.63M shares), and STATE STREET CORP (1.32M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.